Abstract
Surgical resection is not the standard of care for primary central nervous system lymphoma (PCNSL), as historical studies have demonstrated unfavorable complication rates and limited benefits. Some recent studies suggest that resection may provide a therapeutic benefit, yet the safety of these procedures has not been systematically investigated in the setting of modern neurosurgery. We examined the safety of surgical resection for PCNSL. We retrospectively analyzed all patients with PCNSL treated at Columbia University Medical Center between 2000 and 2015 to assess complications rates following biopsy or resection using the Glioma Outcomes Project system. We identified predictors of complications and selection for resection. Well-validated scales were used to quantify patients’ baseline clinical characteristics, including functional status, comorbid disease burden, and cardiac risk. The overall complication rate was 17.2% after resection, and 28.2% after biopsy. Cardiac risk (p = 0.047, OR 1.72 [1.01, 2.95]), and comorbid diagnoses (p = 0.004, OR 3.05 [1.42, 6.57]) predicted complications on multivariable regression. Patients who underwent resection had better KPS scores (median 70 v. 80, p = 0.0068, ∆ 10 [0.0, 10.00]), and were less likely to have multiple (46.5% v. 27.6%, p = 0.030, OR 1.42 [1.05, 1.92]) or deep lesions (70.4% v. 39.7%, p = 0.001, OR 1.83 [1.26, 2.65]). Age (p = 0.048, OR 0.75 per 10-year increase [0.56, 1.00]) and deep lesions (p = 0.003, OR 0.29 [0.13, 0.65]) influenced selection for resection on multivariable regression. Surgical resection of PCNSL is safe for select patients, with complication rates comparable to rates for other intracranial neoplasms. Whether there is a clinical benefit to resection cannot be concluded.
Similar content being viewed by others
References
Bataille B, Delwail V, Menet E, Vandermarcq P, Ingrand P, Wager M, Guy G, Lapierre F (2000) Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg 92:261–266
Weller M, Martus P, Roth P, Thiel E, Korfel A (2012) Surgery for primary CNS lymphoma? Challenging a paradigm. Neuro Oncol 14:1481–1484
Bierman PJ (2014) Surgery for primary central nervous system lymphoma: is it time for reevaluation? Oncology (Williston Park, NY) 28
Siasios I, Fotiadou A, Fotakopoulos G, Ioannou M, Anagnostopoulos V, Fountas K (2015) Primary diffuse large B-cell lymphoma of central nervous system: is still surgery an unorthodox treatment? J Clin Med Res 7:1007
Henry JM, Heffner RR, Dillard SH, Earle KM, Davis RL (1974) Primary malignant lymphomas of the central nervous system. Cancer 34:1293–1302
DeAngelis LM, Yahalom J, Heinemann MH, Cirrincione C, Thaler HT, Krol G (1990) Primary CNS lymphoma combined treatment with chemotherapy and radiotherapy. Neurology 40:80–80
Murray K, Kun L, Cox J (1986) Primary malignant lymphoma of the central nervous system: results of treatment of 11 cases and review of the literature. J Neurosurg 65:600–607
Abrey LE, Yahalom J, DeAngelis LM (2000) Treatment for primary CNS lymphoma: the next step. J Clin Oncol 18:3144–3150
Tomlinson FH, Kurtin PJ, Suman VJ, Scheithauer BW, O’Fallon JR, Kelly PJ, Jack Jr CR, O’Neill BP (1995) Primary intracerebral malignant lymphoma: a clinicopathological study of 89 patients. J Neurosurg 82:558–566
Frank G, Ferracini R, Spagnolli F, Frank F, Gaist G, Lorenzini P, Ricci R (1985) Primary intracranial lymphomas. Surg Neurol 23:3–8
Gonzalez DG, Schuster-Uitterhoeve ALJ (1983) Primary non-Hodgkin’s lymphoma of the central nervous system. Results of radiotherapy in 15 cases. Cancer 51:2048–2052
Helle TL, Britt RH, Colby TV (1984) Primary lymphoma of the central nervous system: clinicopathological study of experience at Stanford. J Neurosurg 60:94–103
Mendenhall NP, Thar TL, Frank O, Harty-Golder B, Ballinger WE, Million RR (1983) Primary lymphoma of the central nervous system. Computerized tomography scan characteristics and treatment results for 12 cases. Cancer 52:1993–2000
Marcus R, Hodson D, Coupland S, Bessell E, Mead B, Pettitt AR (2009) Guidelines on the diagnosis and management of adult patients with primary CNS lymphoma (PCNSL) and primary intra-ocular lymphoma (PIOL)
Bellinzona M, Roser F, Ostertag H, Gaab RM, Saini M (2005) Surgical removal of primary central nervous system lymphomas (PCNSL) presenting as space occupying lesions: a series of 33 cases. Eur J Surg Oncol (EJSO) 31:100–105
Finks JF, Osborne NH, Birkmeyer JD (2011) Trends in hospital volume and operative mortality for high-risk surgery. N Engl J Med 364:2128–2137. doi:10.1056/NEJMsa1010705
Deyo RA, Mirza SK, Martin BI, Kreuter W, Goodman DC, Jarvik JG (2010) Trends, major medical complications, and charges associated with surgery for lumbar spinal stenosis in older adults. JAMA 303:1259–1265
Patil PG, Turner DA, Pietrobon R (2005) National trends in surgical procedures for degenerative cervical spine disease: 1990–2000. Neurosurgery 57:753–758
Cheney FW, Posner KL, Lee LA, Caplan RA, Domino KB (2006) Trends in anesthesia-related death and brain damage. Anesthesiology 105:1081–1086
Smith-Bindman R, Miglioretti DL, Johnson E, Lee C, Feigelson HS, Flynn M, Greenlee RT, Kruger RL, Hornbrook MC, Roblin D (2012) Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996–2010. JAMA 307:2400–2409
Gumprecht HK, Widenka DC, Lumenta CB (1999) BrainLab VectorVision Neuronavigation System: technology and clinical experiences in 131 cases. Neurosurgery 44:97–104
Schebesch K-M, Hoehne J, Hohenberger C, Acerbi F, Broggi M, Proescholdt M, Wendl C, Riemenschneider MJ, Brawanski A (2015) Fluorescein sodium-guided surgery in cerebral lymphoma. Clin Neurol Neurosurg 139:125–128
Hoang-Xuan K, Bessell E, Bromberg J, Hottinger AF, Preusser M, Rudà R, Schlegel U, Siegal T, Soussain C, Abacioglu U (2015) Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology. Lancet Oncol 16:e322–e332
Karnofsky DA (1949) The clinical evaluation of chemotherapeutic agents in cancer. Evaluation of chemotherapeutic agents
Chang SM, Parney IF, McDermott M, Barker FG 2nd, Schmidt MH, Huang W, Laws ER Jr, Lillehei KO, Bernstein M, Brem H, Sloan AE, Berger M (2003) Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma outcome project. J Neurosurg 98:1175–1181. doi:10.3171/jns.2003.98.6.1175
Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, Sugarbaker DJ, Donaldson MC, Poss R, Ho KK, Ludwig LE, Pedan A, Goldman L (1999) Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 100:1043–1049
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383
D’Amico RS, Cloney MB, Sonabend AM, Zacharia B, Nazarian MN, Iwamoto FM, Sisti MB, Bruce JN, McKhann GM (2015) The safety of surgery in elderly patients with primary and recurrent glioblastoma. World Neurosurg. doi:10.1016/j.wneu.2015.05.072.
Patil CG, Lad SP, Santarelli J, Boakye M (2007) National inpatient complications and outcomes after surgery for spinal metastasis from 1993 to 2002. Cancer 110:625–630
Curry WT, McDermott MW, Carter BS, Barker FG 2nd (2005) Craniotomy for meningioma in the United States between 1988 and 2000: decreasing rate of mortality and the effect of provider caseload. J Neurosurg 102:977–986. doi:10.3171/jns.2005.102.6.0977
Barker FG 2nd, Curry WT Jr, Carter BS (2005) Surgery for primary supratentorial brain tumors in the United States, 1988 to 2000: the effect of provider caseload and centralization of care. Neuro Oncol 7:49–63. doi:10.1215/S1152851704000146
Zada G, Du R, Laws Jr ER (2011) Defining the “edge of the envelope”: patient selection in treating complex sellar-based neoplasms via transsphenoidal versus open craniotomy: clinical article. J Neurosurg 114:286–300
Brell M, Ibanez J, Caral L, Ferrer E (2000) Factors influencing surgical complications of intra-axial brain tumours. Acta Neurochir (Wien) 142:739–750
Sawaya R, Hammoud M, Schoppa D, Hess KR, Wu SZ, Shi W-M, Wildrick DM (1998) Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 42:1044–1055
Hoover JM, Nwojo M, Puffer R, Mandrekar J, Meyer FB, Parney IF (2013) Surgical outcomes in recurrent glioma. J Neurosurg. doi:10.3171/2013.2.JNS121731
Moiyadi AV, Shetty PM (2012) Perioperative outcomes following surgery for brain tumors: objective assessment and risk factor evaluation. J Neurosci Rural Pract 3:28
Talacchi A, Turazzi S, Locatelli F, Sala F, Beltramello A, Alessandrini F, Manganotti P, Lanteri P, Gambin R, Ganau M, Tramontano V, Santini B, Gerosa M (2010) Surgical treatment of high-grade gliomas in motor areas. The impact of different supportive technologies: a 171-patient series. J Neurooncol 100:417–426. doi:10.1007/s11060-010-0193-x
Malone HR, Cloney M, Yang J, Neugut AI, Bruce JN (2015) Hospital surgical volume as a source of variation in failure to rescue and inpatient mortality following craniotomy for resection of intracranial neoplasms. 2015 congress of neurological surgeons annual meeting. Congress of Neurological Surgeons, New Orleans, LA
Benz RJ, Ibrahim ZG, Afshar P, Garfin SR (2001) Predicting complications in elderly patients undergoing lumbar decompression. Clin Orthop Relat Res 384:116–121
Birim Ö, Maat A, Kappetein AP, Van Meerbeeck JP, Damhuis RAM, Bogers A (2003) Validation of the Charlson comorbidity index in patients with operated primary non-small cell lung cancer. Eur J Cardio-thorac Surg 23:30–34
Singh B, Bhaya M, Stern J, Roland JT, Zimbler M, Rosenfeld RM, Har-El G, Lucente FE (1997) Validation of the Charlson comorbidity index in patients with head and neck cancer: a multi-institutional study. Laryngoscope 107:1469–1475
Tanaka S, Meyer FB, Buckner JC, Uhm JH, Yan ES, Parney IF (2013) Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients. J Neurosurg 118:786–798 doi:10.3171/2012.10.JNS112268
Hochberg FH, Miller DC (1988) Primary central nervous system lymphoma. J Neurosurg 68:835–853
Michalski JM, Garcia DM, Kase E, Grigsby PW, Simpson JR (1990) Primary central nervous system lymphoma: analysis of prognostic variables and patterns of treatment failure. Radiology 176:855–860
Pollack IF, Dade Lunsford L, Flickinger JC, Lee Dameshek H (1989) Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma. Cancer 63:939–947
Iwamoto FM, Cooper AR, Reiner AS, Nayak L, Abrey LE (2009) Glioblastoma in the elderly: the memorial Sloan-Kettering cancer center experience (1997–2007). Cancer 115:3758–3766 doi:10.1002/cncr.24413
Sonabend AM, Zacharia BE, Cloney MB, Sonabend A, Showers C, Ebiana V, Nazarian M, Swanson KR, Baldock A, Brem H (2016) Defining glioblastoma resectability through the wisdom of the crowd: a proof-of-principle study. Neurosurgery
Orringer D, Lau D, Khatri S, Zamora-Berridi GJ, Zhang K, Wu C, Chaudhary N, Sagher O (2012) Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival. J Neurosurg. doi:10.3171/2012.8.jns12234
Funding
NIH office of the Director, Award Number 1DP5OD021356-01, and Diversity Recruitment Award by the Office of Senior Associate Provost for Faculty Diversity and Inclusion, Columbia University.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Additional information
Michael Brendan Cloney and Adam Sonabend contributed equally to this manuscript, and are co-first authors.
Rights and permissions
About this article
Cite this article
Cloney, M.B., Sonabend, A.M., Yun, J. et al. The safety of resection for primary central nervous system lymphoma: a single institution retrospective analysis. J Neurooncol 132, 189–197 (2017). https://doi.org/10.1007/s11060-016-2358-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-016-2358-8